|
APH1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.942300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.030200E-02 |
| Normal-vs-Stage2 |
2.496100E-02 |
| Normal-vs-Stage3 |
5.397800E-01 |
| Normal-vs-Stage4 |
8.399600E-01 |
| Stage1-vs-Stage2 |
3.532000E-01 |
| Stage1-vs-Stage3 |
8.322200E-02 |
| Stage1-vs-Stage4 |
7.111600E-02 |
| Stage2-vs-Stage3 |
5.648000E-02 |
| Stage2-vs-Stage4 |
4.377800E-02 |
| Stage3-vs-Stage4 |
4.571200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.217780E-01 |
| Normal-vs-AfricanAmerican |
2.919800E-01 |
| Normal-vs-Asian |
3.949600E-01 |
| Caucasian-vs-AfricanAmerican |
5.501900E-02 |
| Caucasian-vs-Asian |
7.673000E-01 |
| AfricanAmerican-vs-Asian |
1.163780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.611410E-01 |
| Normal-vs-Female |
5.708500E-02 |
| Male-vs-Female |
8.040400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.364300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.078620E-01 |
| Normal-vs-Age(61-80Yrs) |
3.284800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.012800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.599200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.738000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.461750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.262000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.011200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.159800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.901800E-01 |
| Classical-VS-Follicular |
4.36190000000503E-05 |
| Classical-VS-Other |
7.765500E-02 |
| Classical-VS-Normal |
5.395200E-01 |
| Tall-VS-Follicular |
3.462500E-03 |
| Tall-VS-Other |
7.230500E-02 |
| Tall-VS-Normal |
8.513000E-01 |
| Follicular-VS-Other |
9.224800E-01 |
| Follicular-VS-Normal |
1.404400E-04 |
| Other-VS-Normal |
3.830100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.925930E-02 |
| Normal-vs-N1 |
3.110000E-02 |
| N0-vs-N1 |
5.223600E-01 |
|
|
